Abstract
In a case control study of 287 women aged 15-24 years with malignant melanoma and 574 matched controls, findings relating to oral contraceptive use and other hormone use are reported. Ever having used oral contraceptives was not associated with an increased risk of melanoma (relative risk for ever use of the pill = 1.0). Women with melanoma were, however, more likely to have taken oral contraceptives for long periods of time in the past, the relative risk associated with oral contraceptive use for a total duration of 5 years or longer which had begun at least 10 years before the melanoma was diagnosed being 1.5 (95% confidence interval 1.03 to 2.14) This elevated risk persisted after controlling for the reported hair and skin colour, frequency of moles on the body, place of birth, and measures of sunlight and fluorescent light exposure. Cases were more likely than controls to have used hormones to regulate their periods, hormonal replacement therapy and be given hormone injections to suppress lactation, the respective relative risks being 1.9, 1.4 and 1.4, but none differed significantly from 1.0. These findings suggest that prolonged oral contraceptive use may, after a lag of 10 years or so, increase the risk of malignant melanoma.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adam S. A., Sheaves J. K., Wright N. H., Mosser G., Harris R. W., Vessey M. P. A case-control study of the possible association between oral contraceptives and malignant melanoma. Br J Cancer. 1981 Jul;44(1):45–50. doi: 10.1038/bjc.1981.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bain C., Hennekens C. H., Speizer F. E., Rosner B., Willett W., Belanger C. Oral contraceptive use and malignant melanoma. J Natl Cancer Inst. 1982 Apr;68(4):537–539. [PubMed] [Google Scholar]
- Beral V., Evans S., Shaw H., Milton G. Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol. 1983 Aug;109(2):165–172. doi: 10.1111/j.1365-2133.1983.tb07077.x. [DOI] [PubMed] [Google Scholar]
- Beral V., Evans S., Shaw H., Milton G. Malignant melanoma and exposure to fluorescent lighting at work. Lancet. 1982 Aug 7;2(8293):290–293. doi: 10.1016/s0140-6736(82)90270-7. [DOI] [PubMed] [Google Scholar]
- Beral V., Ramcharan S., Faris R. Malignant melanoma and oral contraceptive use among women in California. Br J Cancer. 1977 Dec;36(6):804–809. doi: 10.1038/bjc.1977.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holly E. A., Weiss N. S., Liff J. M. Cutaneous melanoma in relation to exogenous hormones and reproductive factors. J Natl Cancer Inst. 1983 May;70(5):827–831. [PubMed] [Google Scholar]